1 October 2024 false Taxfiler 2024.6 11592190 business:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 11592190 2024-09-30 11592190 2024-10-01 2025-09-30 11592190 business:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 11592190 business:FilletedAccounts 2024-10-01 2025-09-30 11592190 2025-09-30 11592190 business:Director1 2024-10-01 2025-09-30 11592190 business:RegisteredOffice 2024-10-01 2025-09-30 11592190 2024-09-30 11592190 core:WithinOneYear 2025-09-30 11592190 core:WithinOneYear 2024-09-30 11592190 core:AfterOneYear 2025-09-30 11592190 core:AfterOneYear 2024-09-30 11592190 core:CapitalContributionReserve core:PreviouslyStatedAmount 2025-09-30 11592190 core:CapitalContributionReserve core:PreviouslyStatedAmount 2024-09-30 11592190 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-09-30 11592190 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-09-30 11592190 core:PreviouslyStatedAmount 2025-09-30 11592190 core:PreviouslyStatedAmount 2024-09-30 11592190 business:SmallEntities 2024-10-01 2025-09-30 11592190 countries:EnglandWales 2024-10-01 2025-09-30 11592190 core:FurnitureFittings 2024-10-01 2025-09-30 11592190 core:ComputerEquipment 2024-10-01 2025-09-30 11592190 core:FurnitureFittings 2024-09-30 11592190 core:ComputerEquipment 2024-09-30 11592190 core:FurnitureFittings 2025-09-30 11592190 core:ComputerEquipment 2025-09-30 11592190 2023-10-01 2024-09-30 iso4217:GBP xbrli:pure
Company Registration No. 11592190 (England and Wales)
E.P.G Pharma Ltd Unaudited accounts for the year ended 30 September 2025
E.P.G Pharma Ltd Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
E.P.G Pharma Ltd Company Information for the year ended 30 September 2025
Director
Sherif Mohamed Aboelnaga Elmasry
Company Number
11592190 (England and Wales)
Registered Office
MEDICITY NOTTINGHAM D6 BUILDING THANE ROAD NOTTINGHAM NG90 6BH ENGLAND
Accountants
KM Accountancy Services Ltd 1000 Great West Rd United Business Centre Brentford Greater London Brentford, London TW8 9DW
- 3 -
E.P.G Pharma Ltd Statement of financial position as at 30 September 2025
2025
2024
Notes
£
£
Fixed assets
Tangible assets
4
356
559
Current assets
Inventories
38,600
38,600
Debtors
5
-
1,397
Cash at bank and in hand
1,250
1,974
39,850
41,971
Creditors: amounts falling due within one year
6
(4,326)
(156,393)
Net current assets/(liabilities)
35,524
(114,422)
Total assets less current liabilities
35,880
(113,863)
Creditors: amounts falling due after more than one year
7
(7,339)
(11,665)
Net assets/(liabilities)
28,541
(125,528)
Capital and reserves
Capital contribution reserve
179,236
-
Profit and loss account
(150,695)
(125,528)
Shareholders' funds
28,541
(125,528)
For the year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 8 June 2026 and were signed on its behalf by
Sherif Mohamed Aboelnaga Elmasry Director Company Registration No. 11592190
- 4 -
E.P.G Pharma Ltd Notes to the Accounts for the year ended 30 September 2025
1
Statutory information
E.P.G Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 11592190. The registered office is MEDICITY NOTTINGHAM D6 BUILDING, THANE ROAD, NOTTINGHAM, NG90 6BH, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
20% Straight line basis
Computer equipment
20% Straight line basis
4
Tangible fixed assets
Fixtures & fittings
Computer equipment
Total
£
£
£
Cost or valuation
At cost
At cost
At 1 October 2024
5,911
1,014
6,925
At 30 September 2025
5,911
1,014
6,925
Depreciation
At 1 October 2024
5,911
455
6,366
Charge for the year
-
203
203
At 30 September 2025
5,911
658
6,569
Net book value
At 30 September 2025
-
356
356
At 30 September 2024
-
559
559
5
Debtors
2025
2024
£
£
Amounts falling due within one year
VAT
-
1,397
- 5 -
E.P.G Pharma Ltd Notes to the Accounts for the year ended 30 September 2025
6
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans and overdrafts
4,326
4,326
Loans from directors
-
152,067
4,326
156,393
7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans
7,339
11,665
8
Average number of employees
During the year the average number of employees was 1 (2024: 1).
- 6 -